Activation of Wnt/β-catenin signaling inhibits amyloid-β production and tau protein hyperphosphorylation in the brain, and a dysregulation in this signaling has been shown to play an important role in AD pathogenesis [69, 70]. The gene discussed is MAPT; the disease is Alzheimer disease.